Oncology & Cancer

Researchers identify new way to make cancer self-destruct

For years, researchers have been trying to target a gene called MYC that is known to drive tumor growth in multiple cancer types when it is mutated or over-expressed, but hitting that target successfully has proven difficult. ...

Oncology & Cancer

Pushing MYC inhibition closer to the clinic

Cutting-edge sequencing technology has revolutionized cancer diagnosis and since identified several so-called cancer driver genomic aberrations. This has led to the development of an extensive and powerful arsenal of anti-cancer ...

Oncology & Cancer

Mapping oesophageal cancer genes leads to new drug targets

Mutations that cause oesophageal adenocarcinoma (OAC) have been mapped in unprecedented detail—unveiling that more than half could be targeted by drugs currently in trials for other cancer types.

Oncology & Cancer

A new approach to detecting cancer earlier from blood tests: study

Cancer scientists led by principal investigator Dr. Daniel De Carvalho at Princess Margaret Cancer Centre have combined "liquid biopsy", epigenetic alterations and machine learning to develop a blood test to detect and classify ...

page 12 from 40